sulfur has been researched along with thromboplastin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, JA; Fredenburgh, JC; Ghazarossian, V; Guo, YS; Hirsh, J; Stafford, AR; Weitz, JI | 1 |
Ishii, H; Murayama, N; Sasaki, T; Sugimoto, K; Takada, K; Yamamoto, K; Yamazaki, H; Yoshimoto, N | 1 |
2 other study(ies) available for sulfur and thromboplastin
Article | Year |
---|---|
Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase.
Topics: Anticoagulants; Antithrombins; Binding Sites; Blood Coagulation; Buffers; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Factor Xa; Glycosaminoglycans; Heparin; Humans; Inhibitory Concentration 50; Kinetics; Neoplasm Proteins; Partial Thromboplastin Time; Periodic Acid; Phospholipids; Protein Binding; Sulfur; Thromboplastin; Time Factors | 2001 |
Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis.
Topics: Administration, Intravenous; Administration, Oral; Amino Acids; Animals; Carboxypeptidase B2; Fibrinolysis; Fibrinolytic Agents; Humans; Lysine; Male; Rats; Sulfur Compounds; Thromboplastin; Thrombosis | 2012 |